Clinical impact of a biomechanical deformable registration volumetric image method for percutaneous Ablation on patients with malignant Liver Lesions COVER-ALL
MD Anderson Study Status
This phase II trial studies how well software-aided imaging works in confirming tumor coverage with ablation (the removal or destruction of a body part or tissue or its function) on patients with liver tumors. The current standard for targeting tumor cells and evaluating the outcome of a liver ablation procedure is a visual inspection of the pre- and post-procedure computed tomography (CT) scans. Software-aided imaging systems, such as Morfeus, may help to improve the accuracy and effectiveness of liver ablation.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Malignant Liver Neoplasm
For general questions about clinical trials: